Further evidence that the neurodevelopmental gene FBXW7 predisposes to Wilms tumor
American Journal of Medical Genetics Part A · 2024
DOI: 10.1002/ajmg.a.63528 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Fabienne Meier-Abt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Genetics, University of Zurich, Schlieren, Switzerland. Hauptthemen laut MEDLINE: F-Box-WD Repeat-Containing Protein 7, Genetic Predisposition to Disease, Wilms Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University Research Priority Program of the University of Zurich ITINERARE - Innovative Therapies in Rare Diseases.
Abstract (Originalsprache)
Somatic variants in the NOTCH pathway regulator FBXW7 are frequently seen in a variety of malignancies. Heterozygous loss‐of‐function germline variants in FBXW7 have recently been described as causative for a neurodevelopmental syndrome. Independently, FBXW7 was also considered as a susceptibility gene for Wilms tumor due to a few observations of heterozygous germline variants in patients with Wilms tumor. Whether the same FBXW7 variants are implicated in both, neurodevelopmental delay and Wilms tumor formation, remained unclear. By clinical testing, we now observed a patient with neurodevelopmental delay due to a de novo constitutional mosaic FBXW7 splice site pathogenic variant who developed Wilms tumor. In the tumor, we identified a second hit frameshift variant in FBXW7 . Immunohistochemical staining was consistent with mosaic loss of FBXW7 protein expression in the tumor. Our data support the role of constitutional FBXW7 pathogenic variants in both, neurodevelopmental disorder and the etiology of Wilms tumor. Therefore, Wilms tumor screening should be considered in individuals with constitutional or germline pathogenic variants in FBXW7 and associated neurodevelopmental syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Genetics, University of Zurich, Schlieren, Switzerland.
- Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
- Department of Pathology, University Hospital Zurich, Zurich, Switzerland.
- Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland.
- University Children's Hospital Zurich, Zurich, Switzerland.
ORCID-Profile: Fabienne Meier-Abt, Anita Rauch
Förderung
- University Research Priority Program of the University of Zurich ITINERARE - Innovative Therapies in Rare Diseases
Zitieren
APA
Meier-Abt, F., Kraemer, D., Braun, N., Reinehr, M., Stutz-Grunder, E., Steindl, K., & Rauch, A. (2024). Further evidence that the neurodevelopmental gene FBXW7 predisposes to Wilms tumor. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63528
Vancouver
Meier-Abt F, Kraemer D, Braun N, Reinehr M, Stutz-Grunder E, Steindl K, et al. Further evidence that the neurodevelopmental gene FBXW7 predisposes to Wilms tumor. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63528
BibTeX
@article{MeierAbt2024,
author = {Meier-Abt, Fabienne and Kraemer, Dennis and Braun, Nils and Reinehr, Michael and Stutz-Grunder, Eveline and Steindl, Katharina and Rauch, Anita},
title = {Further evidence that the neurodevelopmental gene FBXW7 predisposes to Wilms tumor},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
doi = {10.1002/ajmg.a.63528}
}
EUVIMED